Loudoun News

Syneron Bio Closes Nearly $100M in Series A and A+ Rounds

BEIJING, Dec. 18, 2025 /PRNewswire/ -- Syneron Bio, an macrocyclic peptide drug discovery company driven by intelligent high-throughput platform, has successfully completed its Series A and A+ financing rounds, raising…

Theralytics Successfully Completes SOC 2 Type II Audit

ST. PETERSBURG, Fla., Dec. 18, 2025 /PRNewswire/ -- Theralytics, one of the highest-rated ABA practice management and data collection platforms, today announced the successful completion of its SOC 2 Type…